Zimmer Biomet announced FDA 510(k) clearance of the Identity™ Shoulder System for anatomic, reverse and revision shoulder replacement. Identity is a convertible system that uses proprietary technologies to align each surgeon’s approach to an individual patient’s anatomy.
The Identity Shoulder expands on the traditional inlay and onlay reconstruction used in reverse shoulder arthroplasty by providing eight humeral tray combinations that give surgeons increased options for aligning the humerus with the glenoid, without lengthening the arm. Designed to offer adaptability for potential revision procedures in the future, the Identity Shoulder allows for 5mm of additional joint space below resection, which gives surgeons more to work with if a revision is needed in the future.
Similar to all shoulder systems in Zimmer Biomet’s portfolio, the Identity Shoulder utilizes proprietary technologies such as Versa-Dial® for infinite humeral head offset placement and Alliance® Glenoid for a broad range of glenoid options, to adapt to a patient’s unique anatomy.
Identity expands Zimmer Biomet’s upper extremities portfolio, which includes the Comprehensive® Nano Stemless Shoulder and the Signature™ ONE Surgical Planning System, part of the ZBEdge Shoulder ecosystem.
“The FDA clearance of the Identity Shoulder System is exciting because it offers surgeons a highly adaptable solution for anatomic, reverse and revision procedures to help patients optimize natural shoulder movement,” said Ivan Tornos, Chief Operating Officer at Zimmer Biomet. “This significant milestone adds to progress in our growing Sports Medicine, Extremities and Trauma (S.E.T.) portfolio, a critical area of focus as we expand our position as a global leader in innovative medical technologies that maximize mobility.”
Zimmer Biomet announced FDA 510(k) clearance of the Identity™ Shoulder System for anatomic, reverse and revision shoulder replacement. Identity is a convertible system that uses proprietary technologies to align each surgeon's approach to an individual patient's anatomy.
The Identity Shoulder expands on the traditional inlay and onlay...
Zimmer Biomet announced FDA 510(k) clearance of the Identity™ Shoulder System for anatomic, reverse and revision shoulder replacement. Identity is a convertible system that uses proprietary technologies to align each surgeon’s approach to an individual patient’s anatomy.
The Identity Shoulder expands on the traditional inlay and onlay reconstruction used in reverse shoulder arthroplasty by providing eight humeral tray combinations that give surgeons increased options for aligning the humerus with the glenoid, without lengthening the arm. Designed to offer adaptability for potential revision procedures in the future, the Identity Shoulder allows for 5mm of additional joint space below resection, which gives surgeons more to work with if a revision is needed in the future.
Similar to all shoulder systems in Zimmer Biomet’s portfolio, the Identity Shoulder utilizes proprietary technologies such as Versa-Dial® for infinite humeral head offset placement and Alliance® Glenoid for a broad range of glenoid options, to adapt to a patient’s unique anatomy.
Identity expands Zimmer Biomet’s upper extremities portfolio, which includes the Comprehensive® Nano Stemless Shoulder and the Signature™ ONE Surgical Planning System, part of the ZBEdge Shoulder ecosystem.
“The FDA clearance of the Identity Shoulder System is exciting because it offers surgeons a highly adaptable solution for anatomic, reverse and revision procedures to help patients optimize natural shoulder movement,” said Ivan Tornos, Chief Operating Officer at Zimmer Biomet. “This significant milestone adds to progress in our growing Sports Medicine, Extremities and Trauma (S.E.T.) portfolio, a critical area of focus as we expand our position as a global leader in innovative medical technologies that maximize mobility.”
Copy to clipboard 
